Original Research Article
DOI: http://dx.doi.org/10.18203/issn.2455-4510.IntJResOrthop20194810
Clinical outcome of combined scaphocapitate fusion and posterior interosseous neurectomy for stage III Kienbock’s disease
Department of Orthopaedic Surgery, Kafr Eldawar General Hospital, Egypt
Received: 19 August 2019
Revised: 12 October 2019
Accepted: 14 October 2019
*Correspondence:
Dr. Hossam Elden A. Abodonia,
E-mail: dr_hossamabodonia@yahoo.com
Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
ABSTRACT
Background: Treatment of Kienbock’s disease is still controversial. Several authors have described various surgical treatment options for Kienbock’s disease, all of whom reported successful treatment outcomes. The purpose of this study is to explore the clinical results of posterior interosseous neurectomy and scaphocapitate fusion as a treatment option for stage III Kienbock’s disease.
Methods: This study evaluated the range of motion, grip and functional results after treatment of ten wrists of stage III Kienbock’s disease. Four males and six females with average age of 26.3 years, seven dominant and three non-dominant wrists were included. Two patients were smokers while six were housewives, three manual workers and a lawyer. The average follow up period was 14.2 months.
Results: Four patients revealed excellent, three good and three fair results. The mean modified Mayo score was 81.5. Flexion-extension range was 105.5° representing 74.9% of the contralateral side range. The mean flexion and extension range of operated side was increased, while the flexion increase was nonsignificant. Regarding radial-ulnar deviation, the mean range was 33.5° representing 76.5% of the contralateral side. The mean ulnar and radial deviation was increased, while the radial increase was nonsignificant. The mean grip strength was significantly increased to 90 mmHg representing 93.2% of the contralateral side.
Conclusions: Scaphocpitate fusion is a recommended solution for treatment of late stages of Kienbock’s disease with lunate collapse. Longer postoperative time has a positive impact on grip strength and flexion-extension range of motion.
Keywords: Kienbock, Scaphocapitate fusion, Posterior interosseous neurectomy
INTRODUCTION
Robert Kienbock, an Austrian radiologist, first described osteonecrosis of the lunate in 1910.1 However Kienbock’s disease is idiopathic, some theories implicate mechanical influences on the lunate. Several anatomical risk factors are proposed and include negative ulnar variance, variations in lunate shape and radial inclination and a greater palmar tilt of the distal radial articular surface.2
Kienbock’s disease most commonly affects men between the ages of 20 and 40 years. Physical examination reveals tenderness over the dorsum of lunate and radiolunate facet. Motion in the flexion and extension arc is often decreased, and average grip strength may decrease up to 50% of the contralateral side.3
Kienbock’s disease may be staged according to radiologic appearance using Lichtman classification (Table 1).4-6
Transient increases of lunate bone density can be observed after trauma and should not be mistaken for Kienbock’s disease.7 An alternate classification of Kienbock’s disease, the Bain and Begg classification, focuses on the number of nonfunctional articular surfaces of the lunate at arthroscopy.8
Treatment of Kienbock’s disease is still controversial. Several authors have described various surgical treatment options for Kienbock’s disease, all of whom reported successful treatment outcomes. Surgical treatment strategies fall into three main categories: biomechanical unloading of the lunate, vascularized bone graft, and salvage.9 The procedures advocated for treating advanced Kienbock’s disease include radius core decompression, vascularized bone graft, radial osteotomy, radial shortening, capitate shortening, limited wrist arthrodesis, implant resection arthroplasty, proximal row carpectomy and total wrist fusion.10-17
Wrist denervation grew in popularity as an adjunct or alternative to salvage procedures for many chronic wrist conditions.18 The goal of wrist denervation is restored or improved hand motion achieved by severing the Aδ and C fibers to the wrist joint. By which pain to the joint theoretically is reduced without compromising motor or sensory function.19 Posterior interosseous sensory neurectomy does not appear to be associated with decreased proprioception of the wrist.20
The purpose of the study was to explore the clinical results of posterior interosseous neurectomy and scaphocapitate fusion as a treatment option for stage III Kienbock’s disease.
METHODS
After approval of ethics committee of orthopedic department, a retrospective cohort study of ten patients with Kienbock’s disease stage III was performed. Through the period from May 2017 to November 2018, those patients went for lunate excision, scaphocapitate fusion and posterior interosseous neurectomy.
All patients presented by central dorsal wrist pain with limitation of wrist motion for months not responding to medical treatment. X-rays revealed sclerosis and collapse of lunate. In some cases, CT scan was used to differentiate Lichman stage III C at which there is coronal fracture of lunate.
One gram ceftriaxone was administered half an hour prior to tourniquet inflation. Dorsal longitudinal skin incision was centered over lister tubercle. Third dorsal compartment was opened and extensor pollicis longus was retracted laterally (Figure 1A).
Posterior interosseous nerve was identified at the floor of the fourth compartment (Figure 1B), two centimeter of the nerve was excised using cautery then the edges were cauterized also. A radially based flap of wrist capsule was done through incisions parallel to dorsal radiotriquetral and intercarpal ligaments’ fibers (Figure 1C). Collapsed lunate was excised and articular surfaces between scaphoid and capitate were removed. Multiple drilling of scaphoid and capitate was done and cancellous bone graft from distal radius was obtained to enhance scaphocapitate union. A joystick K wire at scaphoid was used to correct its flexed position prior to scaphocapitate pinning with two or three K wires (Figure 1D). Wrist capsule and fourth compartment were closed while extensor pollicis longus was left superficial.
Patients were casted in short arm cast for eight weeks while encouraged for fingers movement. Eight weeks postoperative, both cast and pins were removed. A physiotherapy program to enhance range of motion was commenced after cast removal (Figures 2 and 3).
Wrists were assessed for range of motion and function outcome using modified Mayo score at which there is a total of 100 points which are divided among the evaluator’s assessment of pain (25 points), active flexion/extension arc as a percentage of the opposite side (25 points), grip strength as a percentage of the opposite side (25 points), and the ability to return to regular employment or activities (25 points). An excellent result is defined as 90-100 points, good is 80-89, fair is 65-79 points, and poor is less than 65 points.21 Modified sphygmomanometer test was used to evaluate grip strength.22
RESULTS
This study included ten patients with Litchman stage III Kienbock’s disease with average age of 26.3±7.8 (15-37) years. The average follow up period was 14.2±6.8 (6-24) months (Table 2).
The mean preoperative range of motion of affected wrists was 40±3.3 (35-45)° for flexion, 53±7.9 (40-65)° for extension, 19±3.9 (15-25)° for ulnar deviation and 10.5±2.8 (5-15)° for radial deviation. Using modified sphygmomanometer test, grip strength by mmHg was evaluated. The mean preoperative grip strength of affected wrists was 59.5±10.4 (45-75) mmHg.
Out of ten, four patients revealed excellent, three good and three fair results. The mean modified Mayo score was 81.5±11.8 (65-100).
At the end of follow up, flexion-extension range of motion was 105.5±22 (155-85)° representing 74.9±15 (100-53)% of the contralateral side range. The mean flexion range of operated side was non-significantly increased to 47±12.7 (35-75)°, while extension range was significantly increased to 58.5±10 (50-80)°. Regarding radial-ulnar deviation, the mean range was 33.5±6.7 (45-25)° representing 76.5±16 (100-50)% of the contralateral side. The mean ulnar deviation of operated side was significantly increased to 22±3.5 (15-25)°, while radial deviation was non-significantly increased to 11.5±4.1 (5-20)°. The mean grip strength of operated side was significantly increased to 90±14.5 (70-110) mmHg representing 93.2±11 (100-75)% of the contralateral side (Table 3).
There was no statistically significant relation between results and neither age, gender, occupation, smoking nor hand dominance. Regarding follow-up period, It was found that grip strength (p=0.0096), extension-flexion range of motion (p=0.0094) and modified Mayo score (p=0.0007) revealed statistically better results with longer follow-up period. While there was no statistically significant difference between radial-ulnar range of motion and follow-up period (p=0.8577).
DISCUSSION
Although there are many theories explaining the etiology of Kienbock’s disease, it is not fully proved what the cause of lunate necrosis is. Therefore, various techniques were described to deal with each stage of the disease. Regarding late stages with lunate collapse, both limited carpal fusions and proximal raw carpectomy are popular options. Scapho-trapezial-trapezoid and scaphocapitate are the commonest limited carpal fusions. Biomechanical studies have suggested that scaphocapitate fusion shifts forces across the radiolunate and lunocapitate articulations to the radioscaphoid joint.23
Nakamura et al compared 20 patients with Kienbock who were treated with either proximal raw carpectomy or limited carpal fusions.24 Pain improvement was observed in 71% of patients underwent PRC and 85% of those with limited fusions. The average range of wrist flexion-extension did not improve with either method of treatment, although the postoperative range was greater with limited fusions. The average grip strength, compared with the contralateral side, was greater after limited fusions, although the difference was of no statistical significance.
On the other hand, Tambe et al retrospectively compared 18 patients with Lichtman stages IIIB and IV who were treated with total versus limited wrist fusions.25 The authors stated that, although pain after total wrist fusion was significantly improved compared with limited fusions, the improvement of grip strengths and the DASH scores was slightly better in the limited fusion group which has no statistical significance. As expected, the partial wrist fusion group retained some movement while the total wrist fusion group had none.
Luegmair et al reviewed ten patients who underwent scaphocapitate arthrodesis for stage IIIB and IV Kienbock disease (Table 4).26 The authors concluded that, pain was substantially reduced. The mean QuickDASH score was 27. Radiographic analysis showed union in nine patients, maintenance of carpal height with a corrected radioscaphoid angle, and no evidence of ulnar translation. Budoff et al report two cases of ulnar translation of the wrist after scaphocapitate arthrodesis with lunate excision for the treatment of advanced Kienbock’s disease, however; the radioscaphocapitate ligament was intact in both cases.31
Wrist arthroscopy has a rising role in both assessment and treatment of Kienbock’s disease. Arthroscopy provides a direct visualization and allows probing of the articular surfaces which is a more reliable way to asses functioning articulations and hence guide to appropriate intervention. Arthroscopy also enables minimally invasive techniques to be performed.32
CONCLUSION
The presented results demonstrate that scaphocpitate fusion is a recommended solution for treatment of late stages of Kienbock’s disease with lunate collapse. Posterior interosseous neurectomy offers a suitable option to deal with wrist pain. Longer postoperative time has a positive impact on grip strength and flexion-extension range of motion.
Funding: No funding sources
Conflict of interest: None declared
Ethical approval: The study was approved by the institutional ethics committee
REFERENCES
- 1. Lutsky K, Beredjiklian P. Kienbock Disease. J Hand Surg. 2012;37:1942-52.
- 2. van Leeuwen W, Tarabochia M, Schuurman A, Chen N, Ring D. Risk factors of lunate collapse in Kienbock disease. J Hand Surg. 2017;42:883-8.
- 3. Cross D, Matullo K. Kienbock disease. Orthopedic Clin North Am. 2014;45:141-52.
- 4. Nealey E, Petscavage-Thomas J, Chew F, Allan C, Ha A. Radiologic guide to surgical treatment of Kienbock’s disease. Curr Probl Diagn Radiol. 2018;47:103-9.
- 5. Lichtman DM, Lesley NE, Simmons SP. The classification and treatment of Kienbock’s disease: the state of the art and a look at the future. J Hand Surg. 2010;35:549-54.
- 6. Lichtman DM, Pientka WF, Bain GI. Kienbock disease: a new algorithm for the 21st century. J Wrist Surg. 2016;6:2-10.
- 7. Fontaine C. Kienbock's disease. Chirurgie de la Main. 2015;34:4-17.
- 8. Bain GI, Durrant A. An articular-based approach to Kienbock avascular necrosis of the lunate. Tech Hand Up Extrem Surg. 2011;15:41-7.
- 9. Luo J, Diao E. Kienbock’s disease: an approach to treatment. Hand Clin. 2006;22:465-73.
- 10. De Carli P, Zaidenberg E, Alfie V, Donndorff A, Boretto J, Gallucci G. Radius core decompression for Kienbock disease stage IIIA: outcomes at 13 years follow-up. J Hand Surg. 2017;42:752.e1-6.
- 11. Moran S, Cooney W, Berger R, Bishop A, Shin A. The use of the 4+5 extensor compartmental vascularized bone graft for the treatment of Kienbock’s disease. J Hand Surg. 2005;30:50-8.
- 12. Blanco RH, Blanco FR. Osteotomy of the radius without shortening for Kienbock disease: a 10-year follow-up. J Hand Surg. 2012;37:2221-5.
- 13. Afshar A, Eivaziatashbeik K. Long-term clinical and radiological outcomes of radial shortening osteotomy and vascularized bone graft in Kienbock disease. J Hand Surg. 2013;38:289-96.
- 14. Chevrollier J, Pomares G, Huguet S, Dap F, Dautel G. Intracarpal shortening osteotomy for Kienbock's disease: a retrospective study of 28 cases. Orthop Traumatol Surg Res. 2017;103:191-8.
- 15. Iorio M, Kennedy C, Huang J. Limited intercarpal fusion as a salvage procedure for advanced Kienbock disease. Hand. 2014;10:472-6.
- 16. Viljakka T, Tallroth K, Vastamaki M. Long-term outcome (22-36 years) of silicone lunate arthroplasty for Kienbock’s disease. J Hand Surg. 2013;39:405-15.
- 17. Tatebe M, Hirata H, Iwata Y, Hattori T. Limited wrist arthrodesis versus radial osteotomy for advanced Kienbock’s disease-for a fragmented lunate. Hand Surg. 2006;11:9-14.
- 18. Sgromolo N, Cho M, Gower J, Rhee P. partial wrist denervation for idiopathic dorsal wrist pain in an active duty military population. J Hand Surg. 2018;43:1108-12.
- 19. Kadiyala RK, Lombardi JM. Denervation of the wrist joint for the management of chronic pain. J Am Acad Orthop Surg. 2017;25:439-47.
- 20. Patterson R, Van Niel M, Shimko P, Pace C, Seitz W. Proprioception of the Wrist Following Posterior Interosseous Sensory Neurectomy. J Hand Surg. 2010;35:52-6.
- 21. Slutsky DJ. Outcomes assessment in wrist surgery. J Wrist Surg. 2013;2:1-4.
- 22. Martins JC, Aguiar LT, Lara EM, Teixeira-Salmela LF, Faria CD. Assessment of grip strength with the modified sphygmomanometer test: association between upper limb global strength and motor function. Braz J Phys Ther. 2015;19(6):498-506.
- 23. Iwasaki N, Genda E, Barrance PJ, Minami A, Kaneda K, Chao EYS. Biomechanical analysis of limited intercarpal fusion for the treatment of Kienbock's disease: a three-dimensional theoretical study. J Orthop Res. 1998;16:256-63.
- 24. Nakamura R, Horll E, Watanabe K, Nakao E, Kato H, Tsunoda K. Proximal raw carpectomy versus limited wrist arthrodesis for advanced Kienbock's disease. J Hand Surg. 1998;23:741-5.
- 25. Tambe AD, Trail IA, Stanley JK. Wrist fusion versus limited carpal fusion in advanced Kienbock’s disease. Int Orthop J. 2005;29:255-8.
- 26. Luegmair M, Saffar P. Scaphocapitate arthrodesis for treatment of late stage Kienböck disease. J Hand Surg Eu. 2014;39:416-22.
- 27. Rhee P, Lin I, Moran S, Bishop A, Shin A. Scaphocapitate arthrodesis for Kienbock disease. J Hand Surg Am. 2015;40:745-51.
- 28. Ozdemir G, Akgul T, Cicekli O, Yilmaz B, Atbinici H, Yucel F. Lunatum excision and scaphocapitate arthrodesis in Kienbock’s disease. J Orthop Surg. 2017;25:1-5.
- 29. Zakzouk SA. Scaphocapitate arthrodesis is a viable option in advanced Kienbock’s disease. Egyp Orthop J. 2014;49:231-8.
- 30. Charre A, Delclaux S, Apredoai C, Ayel J, Rongieres M, Mansat P. Results of scaphocapitate arthrodesis with lunate excision in advanced Kienbock disease at 10.7-year mean follow-up. J Hand Surg Eu. 2017;43:362-8.
- 31. Budoff J, Gable G. Ulnar translation of scaphocapitate arthrodeses in Kienbock’s disease-two case reports. J Hand Surg. 2005;30:65-8.
- 32. Bain G, Tse W, Ho P, Lichtman D, MacLean S. Kienbock disease and arthroscopy: assessment, classification and treatment. J Wrist Surg. 2016;5:255-60.